CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. Its research programs address serious diseases and include work in areas such as blood disorders, immunology, and other therapeutic fields. The company’s platform focuses on editing genes as a potential way to create new treatment approaches. Its public materials distinguish clinical-stage candidates and research programs from approved medicines, and individual products may have different development and regulatory status.
Claim this company profile
Please sign in to claim this profile.
Company reviews
No approved reviews yet.
Please sign in to write a review. One review per account and company.
